IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories total debt 1991–2026

IDEXX Laboratories's total debt was 972.96M USD on 30 September 2026, down 12.6% on a year before. At the end of fiscal year 2025 it was 976.06M USD.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 2026972.96M-12.58%197.54M-775.43M0.52
FY202531 Dec 2025976.06M-1.10%180.07M-795.99M0.61
FY202431 Dec 2024986.95M-7.53%288.27M-698.68M0.62
FY202331 Dec 20231.07B-27.39%453.93M-613.42M0.72
FY202231 Dec 20221.47B+42.58%112.55M-1.36B2.41
FY202131 Dec 20211.03B+2.77%144.45M-886.56M1.49
FY202031 Dec 20201.00B-6.28%383.93M-619.32M1.59
FY201931 Dec 20191.07B+7.01%90.33M-980.10M6.03
FY201831 Dec 20181.00B-20.68%123.79M-876.49M—
FY201731 Dec 20171.26B+4.73%471.93M-789.15M—
FY201631 Dec 20161.20B+2.91%391.85M-812.26M—
FY201531 Dec 20151.17B+30.15%342.59M-827.50M—
FY201431 Dec 2014899.00M+109.85%322.54M-576.46M7.65
FY201331 Dec 2013428.39M+99.72%279.06M-149.34M0.83
FY201231 Dec 2012214.50M-12.95%223.99M9.49M0.34
FY201131 Dec 2011246.42M+84.89%183.90M-62.52M0.46
FY201031 Dec 2010133.28M+7.58%156.92M23.64M0.23
FY200931 Dec 2009123.88M-20.83%106.73M-17.16M0.24
FY200831 Dec 2008156.48M+98.87%78.87M-77.61M0.36
FY200731 Dec 200778.68M+1,004.32%60.36M-18.32M0.18
FY200631 Dec 20067.13M+1,193.10%96.67M89.54M0.02
FY200531 Dec 2005551.00K-69.56%132.73M132.18M0.00
FY200431 Dec 20041.81M+41.41%137.27M135.46M0.00
FY200331 Dec 20031.28M+25.61%220.71M219.43M0.00
FY200231 Dec 20021.02M-87.84%147.19M146.17M0.00
FY200131 Dec 20018.38M-1.09%79.56M71.18M0.03
FY200031 Dec 20008.47M+120.45%75.20M66.73M0.03
FY199931 Dec 19993.84M-59.12%58.60M54.76M0.01
FY199831 Dec 19989.40M+129.27%109.10M99.70M0.03
FY199731 Dec 19974.10M+36.67%107.00M102.90M0.01
FY199631 Dec 19963.00M+76.47%127.70M124.70M0.01
FY199531 Dec 19951.70M—149.30M147.60M0.01
FY199431 Dec 19940.00—25.20M25.20M0.00
FY199331 Dec 19930.00—18.90M18.90M0.00
FY199231 Dec 19920.00—17.20M17.20M0.00
FY199131 Dec 19910.00—9.30M9.30M0.00

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about IDEXX Laboratories's debt

Source: Financial Modeling Prep